Researchers report a new mechanism that links cigarette smoking and neurodegeneration by establishing a lung–brain axis. Published in Science Advances and led by scientists at the University of Chicago, the study adds molecular detail to a known epidemiological link: earlier research found heavy midlife smoking more than doubled the later risk of Alzheimer’s and related dementias. Rather than only vascular or oxygen effects, the team shows nicotine can prompt active signaling from the lung that alters brain biology.
The signal begins in pulmonary neuroendocrine cells (PNECs), a rare airway cell type that composes less than 1% of lung cells and is hard to study. To overcome this, the researchers made induced PNECs (iPNECs) from human pluripotent stem cells. When exposed to nicotine, these cells released large amounts of exosomes loaded with serotransferrin, a protein that regulates iron. Applied to the body, the finding suggests each puff of a cigarette, cigar or vape could prompt PNECs to release material that alters iron regulation in neurons.
Iron imbalance can drive oxidative damage, mitochondrial dysfunction and higher α-synuclein expression—changes linked to neurodegenerative disease—and can also trigger ferroptosis, a form of programmed cell death connected in past studies to Alzheimer’s and Parkinson’s. The team is now testing whether blocking exosome release might form the basis of future therapies. Direct impact on human treatment remains years away as more research is required.
- Key mechanisms: exosomes, serotransferrin and iron dysregulation.
- Possible pathway to brain: the vagus nerve.
- Longer-term goal: test exosome-blocking therapies.
Difficult words
- neurodegeneration — Gradual loss of neurons and their normal function
- neuroendocrine cell — A lung cell that releases chemical signalsneuroendocrine cells
- exosome — Small vesicle cells release to send molecular messagesexosomes
- serotransferrin — A blood protein that helps transport and regulate iron
- ferroptosis — A form of cell death caused by iron-dependent oxidation
- α-synuclein — A brain protein linked to aggregation in disease
- mitochondrial dysfunction — Impaired energy production inside the cell's mitochondria
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How might the idea of a lung–brain axis change public health messages about smoking?
- What benefits and challenges can you imagine for therapies that block exosome release?
- How could the link between iron regulation and neurodegeneration influence future research on Alzheimer’s or Parkinson’s?
Related articles
Newborn antibiotics change gut bacteria and lung immunity
Researchers at University of Rochester Medicine report that antibiotics given to newborns can alter gut bacteria and reprogram lung immune cells in mice and humans. These changes can last into young adulthood and may affect breathing.
Some chemotherapy drugs trigger immune attack by mimicking viruses
New research finds that some chemotherapy agents can make cancer cells behave like virus‑infected cells. This viral mimicry activates the innate immune system and could let doctors use lower drug doses with better results.
Many pesticides used in Latin America are banned in the EU
A study found that many active pesticide ingredients allowed on major crops in eight Latin American countries are banned or not authorised in the EU. The researchers examined public approval records up to December 2020 and warn of health risks.